Genetic associations of plasma proteins and breast cancer identify potential therapeutic drug candidates
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified nine plasma proteins linked to breast cancer, with ULK3 and CSK showing reduced expression in tumors. Elevated ULK3 correlates with better survival, and targeting these proteins may aid drug development.
Area Of Science
- Oncology
- Molecular Biology
- Immunology
Background
- Breast cancer outcomes require improvement.
- Identifying novel biomarkers and therapeutic targets is crucial.
Purpose Of The Study
- To identify plasma proteins associated with breast cancer.
- To investigate the role of these proteins in tumor biology and immune response.
- To explore potential therapeutic strategies targeting identified proteins.
Main Methods
- Proteomic analysis to identify candidate proteins.
- Bioinformatic analysis of gene expression and immune cell infiltration.
- In vitro experiments using MCF-7 cells to assess protein function.
- Review of existing drug candidates targeting identified proteins.
Main Results
- Nine plasma proteins (ULK3, CSK, ASIP, TLR1, ADH5, SARS2, UBE2N, PEX14) show significant associations with breast cancer.
- Reduced expression of ULK3 and CSK observed in tumor tissues compared to normal tissues.
- Elevated ULK3 expression is linked to improved recurrence-free survival in breast cancer and Luminal A subtype.
- Overexpression of CSK and ULK3 inhibits proliferation and migration of MCF-7 cells.
- Tumor immune cell infiltration analysis reveals complex gene-immune interactions.
Conclusions
- ULK3 and CSK are potential biomarkers and therapeutic targets in breast cancer.
- Targeting identified proteins like ULK3 and CSK may offer new avenues for breast cancer treatment.
- Drug candidates TG100801, Hydrochlorothiazide, and Imatinib show promise for targeting these proteins.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...